15.03.380 Final Product/Stability Testing

(a) Laboratories performing final product testing pursuant to this section must report all results to the Authority, in a manner and timeframe prescribed by the Authority.

(b) Stability testing shall be performed on each brand and form of medical marijuana product as follows:

(1) For testing of open products, stability testing shall be performed for each extract lot, at time zero when opened and then, at a minimum, at 60 days from the date of first analysis. This shall establish use of the product lot within a specified time once opened.

(2) For testing of unopened products, until stability studies have been completed, a registered entity may assign a tentative expiration date based on available stability information. The registered entity must concurrently have stability studies conducted by an approved laboratory to determine the actual expiration date of an unopened product.

(3) For stability testing of both opened and unopened products, each brand shall retain a total THC and total CBD concentration in milligrams per single dose that is required in Subchapter 7. If stability testing demonstrates that a product no longer retains a consistent concentration of THC and CBD pursuant to Subchapter 8 the product shall be deemed no longer suitable for dispensing or consumption. The Authority may request further stability testing of a brand to demonstrate the ongoing stability of the product produced over time.

(4) The Authority may waive any of the requirements of this subsection upon good cause shown.

(c) The laboratory shall track and use an approved method to dispose of any quantity of medical marijuana product that is not consumed in samples used for testing. Disposal of medical marijuana shall mean that the medical marijuana has been rendered unrecoverable and beyond reclamation.

(d) Any submitted medical marijuana products that are deemed unsuitable for testing shall be returned to the registered entity under chain of custody.